Your browser doesn't support javascript.
loading
Molecular basis for the regulation of human glycogen synthase by phosphorylation and glucose-6-phosphate.
McCorvie, Thomas J; Loria, Paula M; Tu, Meihua; Han, Seungil; Shrestha, Leela; Froese, D Sean; Ferreira, Igor M; Berg, Allison P; Yue, Wyatt W.
Afiliación
  • McCorvie TJ; Centre for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
  • Loria PM; Biosciences Institute, The Medical School, Newcastle University, Newcastle upon Tyne, UK.
  • Tu M; Discovery Sciences, Worldwide Research and Development, Pfizer Inc., Groton, CT, USA.
  • Han S; Medicine Design, Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.
  • Shrestha L; Discovery Sciences, Worldwide Research and Development, Pfizer Inc., Groton, CT, USA.
  • Froese DS; Centre for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
  • Ferreira IM; Centre for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
  • Berg AP; Division of Metabolism and Children's Research Center, University Children's Hospital Zürich, University of Zürich, Zürich, Switzerland.
  • Yue WW; Centre for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Nat Struct Mol Biol ; 29(7): 628-638, 2022 07.
Article en En | MEDLINE | ID: mdl-35835870
ABSTRACT
Glycogen synthase (GYS1) is the central enzyme in muscle glycogen biosynthesis. GYS1 activity is inhibited by phosphorylation of its amino (N) and carboxyl (C) termini, which is relieved by allosteric activation of glucose-6-phosphate (Glc6P). We present cryo-EM structures at 3.0-4.0 Å resolution of phosphorylated human GYS1, in complex with a minimal interacting region of glycogenin, in the inhibited, activated and catalytically competent states. Phosphorylations of specific terminal residues are sensed by different arginine clusters, locking the GYS1 tetramer in an inhibited state via intersubunit interactions. The Glc6P activator promotes conformational change by disrupting these interactions and increases the flexibility of GYS1, such that it is poised to adopt a catalytically competent state when the sugar donor UDP-glucose (UDP-glc) binds. We also identify an inhibited-like conformation that has not transitioned into the activated state, in which the locking interaction of phosphorylation with the arginine cluster impedes subsequent conformational changes due to Glc6P binding. Our results address longstanding questions regarding the mechanism of human GYS1 regulation.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glucógeno Sintasa / Glucosa-6-Fosfato Límite: Humans Idioma: En Revista: Nat Struct Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glucógeno Sintasa / Glucosa-6-Fosfato Límite: Humans Idioma: En Revista: Nat Struct Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido